- Report
- February 2026
- 182 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 170 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 221 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 242 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 178 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 244 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 284 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 565 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 475 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 178 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 471 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 480 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 371 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 173 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 278 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 379 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 193 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 166 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 487 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 279 Pages
Global
From €5135EUR$5,850USD£4,467GBP

The mRNA market within the biotechnology industry is a rapidly growing sector that focuses on the development of messenger ribonucleic acid (mRNA) technology. mRNA is a type of genetic material that is used to create proteins and is a key component of gene therapy. mRNA technology has been used to develop treatments for a variety of diseases, including cancer, heart disease, and neurological disorders. mRNA technology has also been used to develop vaccines for infectious diseases.
The mRNA market is driven by the increasing demand for mRNA-based treatments and vaccines, as well as the growing number of applications for mRNA technology. Companies in the mRNA market are focused on developing mRNA-based treatments and vaccines, as well as developing new applications for mRNA technology. Some of the major companies in the mRNA market include Moderna, BioNTech, CureVac, and Arcturus Therapeutics. Show Less Read more